Cat.#: ACPP-1342
| Despition | ORP150 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1029 | Recombinant Human beta Nerve Growth Factor Protein (AC1029) | 50 µg | inquiry |
| ACPP-1422 | Human CKB Protein, Pichia (AC1422) | 10 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1698 | Rat GDNF Protein (AC1698) | 2 µg | inquiry |
| ACPP-1502 | Human DAG1 Protein (AC1502) | 2 µg | inquiry |
| ACPP-1615 | Human CRYBB1 Protein (AC1615) | 5 µg | inquiry |
| ACPP-1239 | PDE7B Blocking Peptide (AC1239) | 250 µg | inquiry |
| ACPP-1504 | Human CPLX1 Protein (AC1504) | 10 µg | inquiry |
| ACPP-1548 | Human FGF 19 Protein, His (AC1548) | 5 µg | inquiry |
| ACPP-1439 | Human NHLH1 Protein (AC1439) | 1 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.